Skip to main content
Erschienen in: Journal of Neural Transmission 4/2013

01.04.2013 | Neurology and Preclinical Neurological Studies - Review Article

Different diagnostic criteria for Parkinson disease: what are the pitfalls?

verfasst von: Roongroj Bhidayasiri, Heinz Reichmann

Erschienen in: Journal of Neural Transmission | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

As there are no definite diagnostic tests or reliable biomarkers for Parkinson disease (PD), its diagnosis still relies on the presence of a combination of cardinal motor features, along with the exclusion of other causes of Parkinsonism and the presence of some of supportive features. To date, several diagnostic criteria have been developed for different purposes through expert opinions or comprehensive review of the literature. However, none of them are without limitations. In this article, we review different diagnostic criteria for PD which have been published in the English medical literature, highlighting specific limitations and pitfalls. With considerable progress in the understanding of PD, particularly in a view of diverse clinical symptomatology and its evolution, it will be difficult to establish a single criterion that is capable of capturing all cases at different disease stages. Rather, we should aim to develop a set of criteria which include a consensus on clinical gold standard or reliable biomarkers at different levels of diagnostic certainty for different purposes. Despite a more refined set of criteria that may aid in the recognition of PD, the accuracy of its diagnosis still largely depends on the observational skills and clinical sensitivity of the treating physician.
Literatur
Zurück zum Zitat Bhidayasiri R, Truong DD (2012) Therapeutic strategies for nonmotor symptoms in early Parkinson’s disease: the case for a higher priority and stronger evidence. Parkinsonism Relat Disord 18(Suppl 1):S110–S113PubMedCrossRef Bhidayasiri R, Truong DD (2012) Therapeutic strategies for nonmotor symptoms in early Parkinson’s disease: the case for a higher priority and stronger evidence. Parkinsonism Relat Disord 18(Suppl 1):S110–S113PubMedCrossRef
Zurück zum Zitat Bhidayasiri R, Saksornchai K, Kaewwilai L, Phanthumchinda K (2011a) A census of movement disorders at a Thai university hospital. J Neurol Sci 301(1–2):31–34PubMedCrossRef Bhidayasiri R, Saksornchai K, Kaewwilai L, Phanthumchinda K (2011a) A census of movement disorders at a Thai university hospital. J Neurol Sci 301(1–2):31–34PubMedCrossRef
Zurück zum Zitat Bhidayasiri R, Wannachai N, Limpabandhu S, Choeytim S, Suchonwanich Y, Tananyakul S et al (2011b) A national registry to determine the distribution and prevalence of Parkinson’s disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson’s disease. Neuroepidemiology 37(3–4):222–230PubMedCrossRef Bhidayasiri R, Wannachai N, Limpabandhu S, Choeytim S, Suchonwanich Y, Tananyakul S et al (2011b) A national registry to determine the distribution and prevalence of Parkinson’s disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson’s disease. Neuroepidemiology 37(3–4):222–230PubMedCrossRef
Zurück zum Zitat Brooks DJ (2012) Parkinson’s disease: diagnosis. Parkinsonism Relat Disord 18(Suppl 1):S31–S33PubMedCrossRef Brooks DJ (2012) Parkinson’s disease: diagnosis. Parkinsonism Relat Disord 18(Suppl 1):S31–S33PubMedCrossRef
Zurück zum Zitat Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Hoppner J, Wunderlich C et al (2012) Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(4):441–447PubMedCrossRef Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Hoppner J, Wunderlich C et al (2012) Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(4):441–447PubMedCrossRef
Zurück zum Zitat Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32(Suppl):S125–S127PubMedCrossRef Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32(Suppl):S125–S127PubMedCrossRef
Zurück zum Zitat Coelho M, Ferreira JJ (2012) Late-stage Parkinson disease. Nat Rev Neurol 8(8):435–442PubMed Coelho M, Ferreira JJ (2012) Late-stage Parkinson disease. Nat Rev Neurol 8(8):435–442PubMed
Zurück zum Zitat de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM (1997) A population perspective on diagnostic criteria for Parkinson’s disease. Neurology 48(5):1277–1281PubMedCrossRef de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM (1997) A population perspective on diagnostic criteria for Parkinson’s disease. Neurology 48(5):1277–1281PubMedCrossRef
Zurück zum Zitat Dotchin C, Walker R (2012) The management of Parkinson’s disease in sub-Saharan Africa. Expert Rev Neurother 12(6):661–666PubMedCrossRef Dotchin C, Walker R (2012) The management of Parkinson’s disease in sub-Saharan Africa. Expert Rev Neurother 12(6):661–666PubMedCrossRef
Zurück zum Zitat Fahn S, Jankovic J, Hallett M (2011) Parkinsonism: clinical features and differential diagnosis. In: Fahn S, Jankovic J, Hallett M (eds) Principles and practice of movement disorders. Saunders, USA, pp 66–92CrossRef Fahn S, Jankovic J, Hallett M (2011) Parkinsonism: clinical features and differential diagnosis. In: Fahn S, Jankovic J, Hallett M (eds) Principles and practice of movement disorders. Saunders, USA, pp 66–92CrossRef
Zurück zum Zitat Forno LS (1987) The Lewy body in Parkinson’s disease. Adv Neurol 45:35–43PubMed Forno LS (1987) The Lewy body in Parkinson’s disease. Adv Neurol 45:35–43PubMed
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39PubMedCrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39PubMedCrossRef
Zurück zum Zitat Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752PubMedCrossRef Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752PubMedCrossRef
Zurück zum Zitat Han M, Nagele E, DeMarshall C, Acharya N, Nagele R (2012) Diagnosis of Parkinson’s disease based on disease-specific autoantibody profiles in human sera. PLoS ONE 7(2):e32383PubMedCrossRef Han M, Nagele E, DeMarshall C, Acharya N, Nagele R (2012) Diagnosis of Parkinson’s disease based on disease-specific autoantibody profiles in human sera. PLoS ONE 7(2):e32383PubMedCrossRef
Zurück zum Zitat Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844PubMedCrossRef Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844PubMedCrossRef
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442PubMedCrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442PubMedCrossRef
Zurück zum Zitat Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992a) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42(6):1142–1146PubMedCrossRef Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992a) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42(6):1142–1146PubMedCrossRef
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992b) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992b) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
Zurück zum Zitat Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993a) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50(2):140–148PubMedCrossRef Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993a) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50(2):140–148PubMedCrossRef
Zurück zum Zitat Hughes AJ, Daniel SE, Lees AJ (1993b) The clinical features of Parkinson’s disease in 100 histologically proven cases. Adv Neurol 60:595–599PubMed Hughes AJ, Daniel SE, Lees AJ (1993b) The clinical features of Parkinson’s disease in 100 histologically proven cases. Adv Neurol 60:595–599PubMed
Zurück zum Zitat Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMedCrossRef Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMedCrossRef
Zurück zum Zitat Hughes AJ, Daniel SE, Ben Shlomo Y, Lees AJ (2002) The accuracy of diagnosis pf parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870PubMedCrossRef Hughes AJ, Daniel SE, Ben Shlomo Y, Lees AJ (2002) The accuracy of diagnosis pf parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870PubMedCrossRef
Zurück zum Zitat Koller WC (1992) How accurately can Parkinson’s disease be diagnosed? Neurology 42(1 Suppl 1):6–16 (discussion 57–60)PubMed Koller WC (1992) How accurately can Parkinson’s disease be diagnosed? Neurology 42(1 Suppl 1):6–16 (discussion 57–60)PubMed
Zurück zum Zitat Larsen JP, Dupont E, Tandberg E (1994) Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89(4):242–251PubMedCrossRef Larsen JP, Dupont E, Tandberg E (1994) Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89(4):242–251PubMedCrossRef
Zurück zum Zitat Louis ED, Klatka LA, Liu Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease. Neurology 48(2):376–380PubMedCrossRef Louis ED, Klatka LA, Liu Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease. Neurology 48(2):376–380PubMedCrossRef
Zurück zum Zitat Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease. Clinical analysis of 100 patients. Neurology 23(8):783–790PubMedCrossRef Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease. Clinical analysis of 100 patients. Neurology 23(8):783–790PubMedCrossRef
Zurück zum Zitat Meara J, Bhowmick BK, Hobson P (1999) Accuracy of diagnosis in patients with presumed Parkinson’s disease. Age Ageing 28(2):99–102PubMedCrossRef Meara J, Bhowmick BK, Hobson P (1999) Accuracy of diagnosis in patients with presumed Parkinson’s disease. Age Ageing 28(2):99–102PubMedCrossRef
Zurück zum Zitat O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ (2008) Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 23(1):101–106PubMedCrossRef O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ (2008) Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 23(1):101–106PubMedCrossRef
Zurück zum Zitat Ozcift A (2012) SVM feature selection based rotation forest ensemble classifiers to improve computer-aided diagnosis of Parkinson disease. J Med Syst 36(4):2141–2147PubMedCrossRef Ozcift A (2012) SVM feature selection based rotation forest ensemble classifiers to improve computer-aided diagnosis of Parkinson disease. J Med Syst 36(4):2141–2147PubMedCrossRef
Zurück zum Zitat Quinn N (1995) Parkinsonism–recognition and differential diagnosis. BMJ 310(6977):447–452PubMedCrossRef Quinn N (1995) Parkinsonism–recognition and differential diagnosis. BMJ 310(6977):447–452PubMedCrossRef
Zurück zum Zitat Rajput AH, Rozdilsky B, Ang L (1991a) Occurrence of resting tremor in Parkinson’s disease. Neurology 41(8):1298–1299PubMedCrossRef Rajput AH, Rozdilsky B, Ang L (1991a) Occurrence of resting tremor in Parkinson’s disease. Neurology 41(8):1298–1299PubMedCrossRef
Zurück zum Zitat Rajput AH, Rozdilsky B, Rajput A (1991b) Accuracy of clinical diagnosis in Parkinsonism–a prospective study. Can J Neurol Sci 18(3):275–278PubMed Rajput AH, Rozdilsky B, Rajput A (1991b) Accuracy of clinical diagnosis in Parkinsonism–a prospective study. Can J Neurol Sci 18(3):275–278PubMed
Zurück zum Zitat Rao G, Fisch L, Srinivasan S, D’Amico F, Okada T, Eaton C et al (2003) Does this patient have Parkinson disease? JAMA 289(3):347–353PubMedCrossRef Rao G, Fisch L, Srinivasan S, D’Amico F, Okada T, Eaton C et al (2003) Does this patient have Parkinson disease? JAMA 289(3):347–353PubMedCrossRef
Zurück zum Zitat Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):284–290PubMedCrossRef Reichmann H (2010) Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):284–290PubMedCrossRef
Zurück zum Zitat Schrag A, Ben-Shlomo Y, Quinn N (2002) How valid is the clinical diagnosis of Parkinson’s disease in the community? J Neurol Neurosurg Psychiatry 73(5):529–534PubMedCrossRef Schrag A, Ben-Shlomo Y, Quinn N (2002) How valid is the clinical diagnosis of Parkinson’s disease in the community? J Neurol Neurosurg Psychiatry 73(5):529–534PubMedCrossRef
Zurück zum Zitat Shi FD, Jia JP (2011) Neurology and neurologic practice in China. Neurology 77(22):1986–1992PubMedCrossRef Shi FD, Jia JP (2011) Neurology and neurologic practice in China. Neurology 77(22):1986–1992PubMedCrossRef
Zurück zum Zitat Siderowf A, Stern MB (2008) Premotor Parkinson’s disease: clinical features, detection, and prospects for treatment. Ann Neurol 64(Suppl 2):S139–S147PubMed Siderowf A, Stern MB (2008) Premotor Parkinson’s disease: clinical features, detection, and prospects for treatment. Ann Neurol 64(Suppl 2):S139–S147PubMed
Zurück zum Zitat Stern MB, Lang A, Poewe W (2012) Toward a redefinition of Parkinson’s disease. Mov Disord 27(1):54–60PubMedCrossRef Stern MB, Lang A, Poewe W (2012) Toward a redefinition of Parkinson’s disease. Mov Disord 27(1):54–60PubMedCrossRef
Zurück zum Zitat van de Loo S, Walter U, Behnke S, Hagenah J, Lorenz M, Sitzer M et al (2010) Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 81(10):1087–1092PubMedCrossRef van de Loo S, Walter U, Behnke S, Hagenah J, Lorenz M, Sitzer M et al (2010) Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 81(10):1087–1092PubMedCrossRef
Zurück zum Zitat van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25(8):969–978PubMedCrossRef van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson’s disease subtypes using cluster analysis: a systematic review. Mov Disord 25(8):969–978PubMedCrossRef
Zurück zum Zitat van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, Marinus J et al (2011) Clinical subtypes of Parkinson’s disease. Mov Disord 26(1):51–58PubMedCrossRef van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, Marinus J et al (2011) Clinical subtypes of Parkinson’s disease. Mov Disord 26(1):51–58PubMedCrossRef
Zurück zum Zitat Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson’s disease. Adv Neurol 53:245–249PubMed Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson’s disease. Adv Neurol 53:245–249PubMed
Metadaten
Titel
Different diagnostic criteria for Parkinson disease: what are the pitfalls?
verfasst von
Roongroj Bhidayasiri
Heinz Reichmann
Publikationsdatum
01.04.2013
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 4/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-1007-z

Weitere Artikel der Ausgabe 4/2013

Journal of Neural Transmission 4/2013 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Review Article

Treatment of Parkinson’s disease in the advanced stage

Neurology and Preclinical Neurological Studies - Original Article

In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic

Neurology and Preclinical Neurological Studies - Review Article

The epidemiology of pain in Parkinson’s disease

Neurology and Preclinical Neurological Studies - Review Article

Sleep and non-motor symptoms in Parkinson’s disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.